Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T97613 | Target Info | |||
Target Name | Melatonin receptor type 1A (MTNR1A) | ||||
Synonyms |
Mel1a receptor; Mel1AR; Mel-1A-R
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | MTNR1A | ||||
Biochemical Class | GPCR rhodopsin | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Melatonin receptor type 1B (MTNR1B) | Successful Target | ||||
UniProt ID | MTR1B_HUMAN | |||||
Gene Name | MTNR1B | |||||
Synonyms |
Mel1b receptor; Mel1b melatonin receptor; Mel-1B-R
Click to Show/Hide
|
|||||
Representative Drug(s) | LY-156735 | Drug Info | Ki = 0.03981 nM | Click to Show More | [1] | |
2 | Ramelteon | Drug Info | Ki = 0.045 nM | [2] | ||
3 | Melatonin | Drug Info | EC50 = 0.069 nM | [3] | ||
Co-Target Name | Quinone reductase 2 (NQO2) | Successful Target | ||||
UniProt ID | NQO2_HUMAN | |||||
Gene Name | NQO2 | |||||
Synonyms |
Quinone oxidoreductase 2; Qui reductase 2; QR2; NRH:quinone oxidoreductase 2; NRH:qui oxidoreductase 2; NQO2; NAD(P)H qui oxidoreductase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | Melatonin | Drug Info | Ki = 27.6 nM | [4] | ||
Co-Target Name | Histamine H3 receptor (H3R) | Clinical trial Target | ||||
UniProt ID | HRH3_HUMAN | |||||
Gene Name | HRH3 | |||||
Synonyms |
Histamine receptor 3; HH3R; GPCR97; G-protein coupled receptor 97; G protein-coupled receptor 97
Click to Show/Hide
|
|||||
Representative Drug(s) | Melatonin | Drug Info | Ki = 0.5 nM | [5] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Synthesis, chiral resolution, absolute configuration assignment and pharmacological evaluation of a series of melatoninergic ligands. Medchemcomm. 2014;5:1303-8. | ||||
REF 2 | Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists. J Med Chem. 2002 Sep 12;45(19):4222-39. | ||||
REF 3 | Novel N-Acetyl Bioisosteres of Melatonin: Melatonergic Receptor Pharmacology, Physicochemical Studies, and Phenotypic Assessment of Their Neurogenic Potential. J Med Chem. 2015 Jun 25;58(12):4998-5014. | ||||
REF 4 | Synthesis of a novel series of benzocycloalkene derivatives as melatonin receptor agonists. J Med Chem. 2002 Sep 12;45(19):4212-21. | ||||
REF 5 | New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H 3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition. J Med Chem. 2019 Dec 26;62(24):11416-11422. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.